Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation

Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation

Abstract Objectives Patients with refractory myasthenia gravis (MG) have few treatment options. Autologous hematopoietic stem cell transplantation (HSCT) has been used to treat immune diseases; however, its use in the treatment of MG is not broadly considered. Our objective is to report on the effic...

Full description

Saved in:
Bibliographic Details
Main Authors: Benjamin Beland, Jan Storek, Liam Quartermain, Christopher Hahn, C. Elizabeth Pringle, Pierre R. Bourque, Michael Kennah, Natasha Kekre, Christopher Bredeson, David Allan, Kareem Jamani, Christopher White, Harold Atkins
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.52246
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items